[Periprocedural high-dose statin strategy shown no benefits on clinical outcomes in patients with coronary artery disease undergoing percutaneous coronary interventions].

Autor: Li Y, Zhao SP, Li Y
Jazyk: čínština
Zdroj: Zhonghua xin xue guan bing za zhi [Zhonghua Xin Xue Guan Bing Za Zhi] 2018 May 24; Vol. 46 (5), pp. 338-340.
DOI: 10.3760/cma.j.issn.0253-3758.2018.05.003
Databáze: MEDLINE